Kiril Domuschiev and Georgi Domuschief
Owners of Huvepharma, one of the largest animal pharmaceutical companies, globally. Number
🤖
AI Overview
With $1.2M in lobbying spend across 19 quarterly filings, Kiril Domuschiev and Georgi Domuschief is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2024 to 2025.
$1.2M
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $975K |
| 2025 | $225K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Government Issues, Animals, Pharmacy
- •US Government relations in general. Assisting them with problems caused by local adversaries.
- •The main objective is to highlight the business activities of Kiril & Georgi Domuschiev in the US & Europe. The focus is on Huvepharma, one of the largest animal pharmaceutical companies in the US. Th
- •Please see previous description
Related Analysis
Related Investigations
DOGE vs. the Lobbying Machine
Government efficiency meets the lobbying industrial complex.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.